Adults with diabetes using an implantable 1-year continuous glucose monitoring sensor had a mean time in range of about 66% ...
Adults with diabetes using an automated insulin delivery system had minimal change in time in range after switching ...
This morning Belgian startup Indigo Diabetes announced a €38 million ($44.6 million) Series B funding round. This round included contributions from new investors Fund+, Ackermans&van Haaren, Capricorn ...
PARSIPPANY, N.J. & GERMANTOWN, Md.--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused ...
The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience "Patients with diabetes can get overwhelmed by the sheer number of ...
It takes two: After making its commercial debut early this year, Dexcom’s latest continuous glucose monitor is wrapping up 2023 by connecting with its first automated insulin pump partner, courtesy of ...
Advances in CGM technology has been life-altering to those living with diabetes. According to the Diabetes Research Institute Foundation, "34.2 million people, or 10.5% of the US population, have ...
Almost 1 in 2 people with diabetes using a short-term CGM are not fully satisfied with their current systemi For the 37 million people living with diabetes in the U.S.ii, CGM has become an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results